Research programme: ADoFuse based antibody drug conjugates - Medicovestor
Latest Information Update: 15 Jan 2024
At a glance
- Originator Medicovestor
- Class Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Gastrointestinal cancer; Ovarian cancer
Most Recent Events
- 18 Dec 2023 Early research in Gastrointestinal cancer in USA (Parenteral) prior to December 2023 (Medicovestor pipeline, December 2023)
- 18 Dec 2023 Early research in Ovarian cancer in USA (Parenteral) prior to December 2023 (Medicovestor pipeline, December 2023)